Figure 1.
Figure 1. Kaplan-Meier estimates of OS from hematologic relapse in patients treated with HDM/SCT for AL amyloidosis. Median OS 8.54 years.

Kaplan-Meier estimates of OS from hematologic relapse in patients treated with HDM/SCT for AL amyloidosis. Median OS 8.54 years.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal